Report Detail
Global Levocetirizine Dihydrochloride API Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
- RnM4638819 |
- 24 October, 2025 |
- Global |
- 124 Pages |
- GIR |
- Chemical & Material
According to our (Global Info Research) latest study, the global Levocetirizine Dihydrochloride API market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Levocetirizine Dihydrochloride is the dihydrochloride salt form of the active levorotatory enantiomer of cetirizine, levocetirizine; a third generation, non-sedating, selective histamine H1 receptor antagonist, with antihistamine, anti-inflammatory and potential anti-angiogenic activities. Levocetirizine competes with endogenous histamine for binding at peripheral H1-receptor sites on the effector cell surface. This prevents the negative symptoms associated with histamine release and an allergic reaction. In addition, as histamine plays an important role in angiogenesis during an allergic inflammatory reaction, blocking the action of histamine may modulate the expression of proangiogenic factors and thus may prevent angiogenesis. As a third-generation histamine H1 receptor antagonist, levocetirizine has fewer side effects than most second-generation antihistamines.
This report is a detailed and comprehensive analysis for global Levocetirizine Dihydrochloride API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Levocetirizine Dihydrochloride API market size and forecasts, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2020-2031
Global Levocetirizine Dihydrochloride API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2020-2031
Global Levocetirizine Dihydrochloride API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2020-2031
Global Levocetirizine Dihydrochloride API market shares of main players, shipments in revenue ($ Million), sales quantity (Ton), and ASP (US$/Ton), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Levocetirizine Dihydrochloride API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Levocetirizine Dihydrochloride API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Dr. Reddy’s Laboratories Ltd., Metrochem API Private Limited, Om Pharmaceutical Industries, Symed Labs Limited, Glenmark Pharmaceuticals, Granules India Limited, Chongqing Huapont Pharmaceutical, Glochem Industries, Cipla, Nishchem International Pvt. Ltd, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Levocetirizine Dihydrochloride API market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Purity≥98%
Purity<98%
Market segment by Application
Levocetirizine Dihydrochloride Tablets
Levocetirizine Dihydrochloride Oral Solution
Others
Major players covered
Dr. Reddy’s Laboratories Ltd.
Metrochem API Private Limited
Om Pharmaceutical Industries
Symed Labs Limited
Glenmark Pharmaceuticals
Granules India Limited
Chongqing Huapont Pharmaceutical
Glochem Industries
Cipla
Nishchem International Pvt. Ltd
Maps Laboratories Private Limited
Supriya Lifescience Limited
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Levocetirizine Dihydrochloride API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Levocetirizine Dihydrochloride API, with price, sales quantity, revenue, and global market share of Levocetirizine Dihydrochloride API from 2020 to 2025.
Chapter 3, the Levocetirizine Dihydrochloride API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Levocetirizine Dihydrochloride API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Levocetirizine Dihydrochloride API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Levocetirizine Dihydrochloride API.
Chapter 14 and 15, to describe Levocetirizine Dihydrochloride API sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Levocetirizine Dihydrochloride API Consumption Value by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 Purity≥98%
- 1.3.3 Purity<98%
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Levocetirizine Dihydrochloride API Consumption Value by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 Levocetirizine Dihydrochloride Tablets
- 1.4.3 Levocetirizine Dihydrochloride Oral Solution
- 1.4.4 Others
- 1.5 Global Levocetirizine Dihydrochloride API Market Size & Forecast
- 1.5.1 Global Levocetirizine Dihydrochloride API Consumption Value (2020 & 2024 & 2031)
- 1.5.2 Global Levocetirizine Dihydrochloride API Sales Quantity (2020-2031)
- 1.5.3 Global Levocetirizine Dihydrochloride API Average Price (2020-2031)
2 Manufacturers Profiles
- 2.1 Dr. Reddy’s Laboratories Ltd.
- 2.1.1 Dr. Reddy’s Laboratories Ltd. Details
- 2.1.2 Dr. Reddy’s Laboratories Ltd. Major Business
- 2.1.3 Dr. Reddy’s Laboratories Ltd. Levocetirizine Dihydrochloride API Product and Services
- 2.1.4 Dr. Reddy’s Laboratories Ltd. Levocetirizine Dihydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.1.5 Dr. Reddy’s Laboratories Ltd. Recent Developments/Updates
- 2.2 Metrochem API Private Limited
- 2.2.1 Metrochem API Private Limited Details
- 2.2.2 Metrochem API Private Limited Major Business
- 2.2.3 Metrochem API Private Limited Levocetirizine Dihydrochloride API Product and Services
- 2.2.4 Metrochem API Private Limited Levocetirizine Dihydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.2.5 Metrochem API Private Limited Recent Developments/Updates
- 2.3 Om Pharmaceutical Industries
- 2.3.1 Om Pharmaceutical Industries Details
- 2.3.2 Om Pharmaceutical Industries Major Business
- 2.3.3 Om Pharmaceutical Industries Levocetirizine Dihydrochloride API Product and Services
- 2.3.4 Om Pharmaceutical Industries Levocetirizine Dihydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.3.5 Om Pharmaceutical Industries Recent Developments/Updates
- 2.4 Symed Labs Limited
- 2.4.1 Symed Labs Limited Details
- 2.4.2 Symed Labs Limited Major Business
- 2.4.3 Symed Labs Limited Levocetirizine Dihydrochloride API Product and Services
- 2.4.4 Symed Labs Limited Levocetirizine Dihydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.4.5 Symed Labs Limited Recent Developments/Updates
- 2.5 Glenmark Pharmaceuticals
- 2.5.1 Glenmark Pharmaceuticals Details
- 2.5.2 Glenmark Pharmaceuticals Major Business
- 2.5.3 Glenmark Pharmaceuticals Levocetirizine Dihydrochloride API Product and Services
- 2.5.4 Glenmark Pharmaceuticals Levocetirizine Dihydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.5.5 Glenmark Pharmaceuticals Recent Developments/Updates
- 2.6 Granules India Limited
- 2.6.1 Granules India Limited Details
- 2.6.2 Granules India Limited Major Business
- 2.6.3 Granules India Limited Levocetirizine Dihydrochloride API Product and Services
- 2.6.4 Granules India Limited Levocetirizine Dihydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.6.5 Granules India Limited Recent Developments/Updates
- 2.7 Chongqing Huapont Pharmaceutical
- 2.7.1 Chongqing Huapont Pharmaceutical Details
- 2.7.2 Chongqing Huapont Pharmaceutical Major Business
- 2.7.3 Chongqing Huapont Pharmaceutical Levocetirizine Dihydrochloride API Product and Services
- 2.7.4 Chongqing Huapont Pharmaceutical Levocetirizine Dihydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.7.5 Chongqing Huapont Pharmaceutical Recent Developments/Updates
- 2.8 Glochem Industries
- 2.8.1 Glochem Industries Details
- 2.8.2 Glochem Industries Major Business
- 2.8.3 Glochem Industries Levocetirizine Dihydrochloride API Product and Services
- 2.8.4 Glochem Industries Levocetirizine Dihydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.8.5 Glochem Industries Recent Developments/Updates
- 2.9 Cipla
- 2.9.1 Cipla Details
- 2.9.2 Cipla Major Business
- 2.9.3 Cipla Levocetirizine Dihydrochloride API Product and Services
- 2.9.4 Cipla Levocetirizine Dihydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.9.5 Cipla Recent Developments/Updates
- 2.10 Nishchem International Pvt. Ltd
- 2.10.1 Nishchem International Pvt. Ltd Details
- 2.10.2 Nishchem International Pvt. Ltd Major Business
- 2.10.3 Nishchem International Pvt. Ltd Levocetirizine Dihydrochloride API Product and Services
- 2.10.4 Nishchem International Pvt. Ltd Levocetirizine Dihydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.10.5 Nishchem International Pvt. Ltd Recent Developments/Updates
- 2.11 Maps Laboratories Private Limited
- 2.11.1 Maps Laboratories Private Limited Details
- 2.11.2 Maps Laboratories Private Limited Major Business
- 2.11.3 Maps Laboratories Private Limited Levocetirizine Dihydrochloride API Product and Services
- 2.11.4 Maps Laboratories Private Limited Levocetirizine Dihydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.11.5 Maps Laboratories Private Limited Recent Developments/Updates
- 2.12 Supriya Lifescience Limited
- 2.12.1 Supriya Lifescience Limited Details
- 2.12.2 Supriya Lifescience Limited Major Business
- 2.12.3 Supriya Lifescience Limited Levocetirizine Dihydrochloride API Product and Services
- 2.12.4 Supriya Lifescience Limited Levocetirizine Dihydrochloride API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.12.5 Supriya Lifescience Limited Recent Developments/Updates
3 Competitive Environment: Levocetirizine Dihydrochloride API by Manufacturer
- 3.1 Global Levocetirizine Dihydrochloride API Sales Quantity by Manufacturer (2020-2025)
- 3.2 Global Levocetirizine Dihydrochloride API Revenue by Manufacturer (2020-2025)
- 3.3 Global Levocetirizine Dihydrochloride API Average Price by Manufacturer (2020-2025)
- 3.4 Market Share Analysis (2024)
- 3.4.1 Producer Shipments of Levocetirizine Dihydrochloride API by Manufacturer Revenue ($MM) and Market Share (%): 2024
- 3.4.2 Top 3 Levocetirizine Dihydrochloride API Manufacturer Market Share in 2024
- 3.4.3 Top 6 Levocetirizine Dihydrochloride API Manufacturer Market Share in 2024
- 3.5 Levocetirizine Dihydrochloride API Market: Overall Company Footprint Analysis
- 3.5.1 Levocetirizine Dihydrochloride API Market: Region Footprint
- 3.5.2 Levocetirizine Dihydrochloride API Market: Company Product Type Footprint
- 3.5.3 Levocetirizine Dihydrochloride API Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Levocetirizine Dihydrochloride API Market Size by Region
- 4.1.1 Global Levocetirizine Dihydrochloride API Sales Quantity by Region (2020-2031)
- 4.1.2 Global Levocetirizine Dihydrochloride API Consumption Value by Region (2020-2031)
- 4.1.3 Global Levocetirizine Dihydrochloride API Average Price by Region (2020-2031)
- 4.2 North America Levocetirizine Dihydrochloride API Consumption Value (2020-2031)
- 4.3 Europe Levocetirizine Dihydrochloride API Consumption Value (2020-2031)
- 4.4 Asia-Pacific Levocetirizine Dihydrochloride API Consumption Value (2020-2031)
- 4.5 South America Levocetirizine Dihydrochloride API Consumption Value (2020-2031)
- 4.6 Middle East & Africa Levocetirizine Dihydrochloride API Consumption Value (2020-2031)
5 Market Segment by Type
- 5.1 Global Levocetirizine Dihydrochloride API Sales Quantity by Type (2020-2031)
- 5.2 Global Levocetirizine Dihydrochloride API Consumption Value by Type (2020-2031)
- 5.3 Global Levocetirizine Dihydrochloride API Average Price by Type (2020-2031)
6 Market Segment by Application
- 6.1 Global Levocetirizine Dihydrochloride API Sales Quantity by Application (2020-2031)
- 6.2 Global Levocetirizine Dihydrochloride API Consumption Value by Application (2020-2031)
- 6.3 Global Levocetirizine Dihydrochloride API Average Price by Application (2020-2031)
7 North America
- 7.1 North America Levocetirizine Dihydrochloride API Sales Quantity by Type (2020-2031)
- 7.2 North America Levocetirizine Dihydrochloride API Sales Quantity by Application (2020-2031)
- 7.3 North America Levocetirizine Dihydrochloride API Market Size by Country
- 7.3.1 North America Levocetirizine Dihydrochloride API Sales Quantity by Country (2020-2031)
- 7.3.2 North America Levocetirizine Dihydrochloride API Consumption Value by Country (2020-2031)
- 7.3.3 United States Market Size and Forecast (2020-2031)
- 7.3.4 Canada Market Size and Forecast (2020-2031)
- 7.3.5 Mexico Market Size and Forecast (2020-2031)
8 Europe
- 8.1 Europe Levocetirizine Dihydrochloride API Sales Quantity by Type (2020-2031)
- 8.2 Europe Levocetirizine Dihydrochloride API Sales Quantity by Application (2020-2031)
- 8.3 Europe Levocetirizine Dihydrochloride API Market Size by Country
- 8.3.1 Europe Levocetirizine Dihydrochloride API Sales Quantity by Country (2020-2031)
- 8.3.2 Europe Levocetirizine Dihydrochloride API Consumption Value by Country (2020-2031)
- 8.3.3 Germany Market Size and Forecast (2020-2031)
- 8.3.4 France Market Size and Forecast (2020-2031)
- 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
- 8.3.6 Russia Market Size and Forecast (2020-2031)
- 8.3.7 Italy Market Size and Forecast (2020-2031)
9 Asia-Pacific
- 9.1 Asia-Pacific Levocetirizine Dihydrochloride API Sales Quantity by Type (2020-2031)
- 9.2 Asia-Pacific Levocetirizine Dihydrochloride API Sales Quantity by Application (2020-2031)
- 9.3 Asia-Pacific Levocetirizine Dihydrochloride API Market Size by Region
- 9.3.1 Asia-Pacific Levocetirizine Dihydrochloride API Sales Quantity by Region (2020-2031)
- 9.3.2 Asia-Pacific Levocetirizine Dihydrochloride API Consumption Value by Region (2020-2031)
- 9.3.3 China Market Size and Forecast (2020-2031)
- 9.3.4 Japan Market Size and Forecast (2020-2031)
- 9.3.5 South Korea Market Size and Forecast (2020-2031)
- 9.3.6 India Market Size and Forecast (2020-2031)
- 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
- 9.3.8 Australia Market Size and Forecast (2020-2031)
10 South America
- 10.1 South America Levocetirizine Dihydrochloride API Sales Quantity by Type (2020-2031)
- 10.2 South America Levocetirizine Dihydrochloride API Sales Quantity by Application (2020-2031)
- 10.3 South America Levocetirizine Dihydrochloride API Market Size by Country
- 10.3.1 South America Levocetirizine Dihydrochloride API Sales Quantity by Country (2020-2031)
- 10.3.2 South America Levocetirizine Dihydrochloride API Consumption Value by Country (2020-2031)
- 10.3.3 Brazil Market Size and Forecast (2020-2031)
- 10.3.4 Argentina Market Size and Forecast (2020-2031)
11 Middle East & Africa
- 11.1 Middle East & Africa Levocetirizine Dihydrochloride API Sales Quantity by Type (2020-2031)
- 11.2 Middle East & Africa Levocetirizine Dihydrochloride API Sales Quantity by Application (2020-2031)
- 11.3 Middle East & Africa Levocetirizine Dihydrochloride API Market Size by Country
- 11.3.1 Middle East & Africa Levocetirizine Dihydrochloride API Sales Quantity by Country (2020-2031)
- 11.3.2 Middle East & Africa Levocetirizine Dihydrochloride API Consumption Value by Country (2020-2031)
- 11.3.3 Turkey Market Size and Forecast (2020-2031)
- 11.3.4 Egypt Market Size and Forecast (2020-2031)
- 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
- 11.3.6 South Africa Market Size and Forecast (2020-2031)
12 Market Dynamics
- 12.1 Levocetirizine Dihydrochloride API Market Drivers
- 12.2 Levocetirizine Dihydrochloride API Market Restraints
- 12.3 Levocetirizine Dihydrochloride API Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Levocetirizine Dihydrochloride API and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Levocetirizine Dihydrochloride API
- 13.3 Levocetirizine Dihydrochloride API Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Levocetirizine Dihydrochloride API Typical Distributors
- 14.3 Levocetirizine Dihydrochloride API Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Levocetirizine Dihydrochloride API. Industry analysis & Market Report on Levocetirizine Dihydrochloride API is a syndicated market report, published as Global Levocetirizine Dihydrochloride API Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Levocetirizine Dihydrochloride API market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
